Logo image
Five-year cost-effectiveness of AI for adult diabetic eye exams—a health system perspective
Journal article   Open access   Peer reviewed

Five-year cost-effectiveness of AI for adult diabetic eye exams—a health system perspective

Mahnoor Ahmed, Michael D. Abramoff, Harold P. Lehmann, Tinglong Dai, Risa M. Wolf and Roomasa Channa
NPJ digital medicine
08/20/2026
DOI: 10.1038/s41746-026-03078-3
url
https://doi.org/10.1038/s41746-026-03078-3View
Published (Version of record) Open Access

Abstract

Teleophthalmology and artificial intelligence (AI) -based retinal screening have emerged as scalable approaches to improve detection of diabetic retinal disease (DRD), yet their economic value within U.S. health systems is not well defined. We developed a 5-year Markov model to evaluate the cost-effectiveness of these alternative strategies against screening by an eye care professional (ECP) across two scenarios: a small primary care network and a large integrated health system with Willingness-to-Pay (WTP) ranges, respectively, of $400–1500 and $800–3500 per patient over 5 years. AI-based strategies yield 3 times more screenings completed, 3.6–3.8 times more true positives, and 7.5–8.0 times more patients who initiate treatment than ECP. Teleophthalmology strategies are moderately effective. The most cost-effective strategy for each scenario depends on health system scale and WTP. For a primary care network with $400 WTP, teleretinal via handheld camera is preferred for sites screening ≤ 2282 patients; handheld AI otherwise. At $1500 WTP, teleretinal via handheld camera is preferred for sites with ≤ 884 patients, handheld AI for 885–1476, and stationary AI otherwise. In an integrated health system at $800 WTP, ECP dominates across volumes of 250–14,000 patients. At $3500 WTP, teleretinal via handheld is preferred for ≤ 1393 patients per site; stationary AI otherwise. AI-based strategies, particularly handheld AI, are cost-effective with larger patient volumes and higher WTP thresholds. Their cost-effectiveness is driven by real-time diagnostic feedback that enables earlier detection and reduces costs associated with managing advanced forms of DRD.

Details

Metrics

1 Record Views
Logo image